Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Ther Drug Monit. 2016 Jun;38(3):332–342. doi: 10.1097/FTD.0000000000000276

Table 2.

Characteristics of the patient cohorts. Data are presented as mean (range). CHLA, Children’s Hospital Los Angeles; Cave, average concentration over 96 hours.

Cohort Model Building Validation 1 Validation 2 BestDose
Source CHLA Lyon CHLA CHLA
Number 53 105 11 20
Age (years) 7.8 (0.2 – 19.0) 5.6 (0.1 – 21) 5.8 (0.5 – 14.2) 10.2 (0.25 – 18)
Weight (kg) 26.5 (5.6 – 78.0) 20.3 (3.4 – 59.6) 22.7 (5.2 – 53.4) 46.4 (5.2 – 110.9)
All Doses (mg/kg) 1.1 (0.7 – 1.8) 1.2 (0.6 – 5.2) 1.2 (0.9 – 1.5) 0.83 (0.5 – 1.3)
Samples/patient 16.7 (6 – 26) 3.3 (1 – 13) 15.9 (8 – 26) 25.2 (17 – 26)
Cave(ng/mL) 750 (390 – 1190) 750 (390 – 1860) 780 (550 – 950) 714 (564 – 914)